Delic Labs

09/14/2022

Delivered by in-industry experts, the webinar on Advances in Psilocybin Research featuring Dr. Markus Roggen, President and CSO of Delic Labs, will provide an exclusive insight into the latest research for the use of psilocybin to satisfy unmet clinical needs and the regulations associated with this drug.

To Register see the following link:

https://www.analyticalcannabis.com/webinars/advances-in-psilocybin-research-314088

07/22/2022

From the Archives of Dr. Markus Roggen:

To keep growing, the cannabis industry must embrace the Dark Side: Big Pharma.

The Big Pharma empire has certainly given us many reasons to be skeptical, starting with Big Pharma’s stakes against cannabis legalization [1], its financial interest in addictive substances like opioids [2], artificial price inflation of life- saving drugs [3], and using patents to prevent innovation. [4] But the pharmaceutical industry is also known for: developing drugs that drastically reduced the prevalence of certain diseases, [5] product purity, [6] extensive clinical trials, [7] and their relatively low recall rates. [8]

Big Pharma has been perfecting its mastery of the Force for at least a century, and as a New Republic, turning away from this wealth of insight and experience would make the budding cannabis industry as bad as Jar Jar Binks. [9] If we don’t learn from the Dark Side, we will be extinguished.
So what does the pharmaceutical industry get right?

For more from Dr. Roggen see this link

https://deliclabs.com/dark-side-of-the-force/

Or check out the link in our Bio to explore all of the Cannabis Testing applications of Delic Labs.

To keep growing, the cannabis industry must embrace the pharmaceutical industry in order to learn product safety, dosage consistencies, and more.

07/11/2022

From the archives of Dr. Markus Roggen.

"If you spend top dollar on a top shelf flower bud, you have a right to know how long it will stay dank", Dr. Markus Roggen argues.

Testing procedures, the effects of cannabinoids and terpenes on the body, and regulations surrounding the industry are always being talked about, but nobody seems to talk about "Best Before" dates and product stability.

Cannabis products are improving in both quality and sophistication every day. Even standardization of active ingredients and medicinal effectiveness is progressing. Our industry is coming out of the shadows and into the limelight and is poised to be an economic driving force in the coming years. Can...

06/29/2022

Give a Voice to Scientists in the Executive Suite - by Dr. Markus Roggen on the Cannabis Industry Journal.

https://cannabisindustryjournal.com/column/give-a-voice-to-scientists-in-the-executive-suite/

We looked at 10 major pharmaceutical companies and 10 major cannabis companies, comparing what positions they had for scientists and their R&D spending. Why are scientists rarely in the c-suite of cannabis companies?